Hospital Universitario de Donostia-ko ikertzaileekin lankidetzan egindako argitalpenak (12)

2023

  1. Correction to: Five-year follow-up mortality prognostic index for colorectal patients (International Journal of Colorectal Disease, (2023), 38, 1, (64), 10.1007/s00384-023-04358-0)

    International Journal of Colorectal Disease

  2. Five-year follow-up mortality prognostic index for colorectal patients

    International Journal of Colorectal Disease, Vol. 38, Núm. 1

2022

  1. Author Correction: Machine learning-based model for prediction of clinical deterioration in hospitalized patients by COVID 19 (Scientific Reports, (2022), 12, 1, (7097), 10.1038/s41598-022-09771-z)

    Scientific Reports

2021

  1. Risk scores to predict mortality 2 and 5 years after surgery for colorectal cancer in elderly patients

    World Journal of Surgical Oncology, Vol. 19, Núm. 1

2020

  1. Predictors of readmission and reoperation in patients with colorectal cancer

    Supportive Care in Cancer, Vol. 28, Núm. 5, pp. 2339-2350

2018

  1. CCR-CARESS score for predicting operative mortality in patients with colorectal cancer

    British Journal of Surgery, Vol. 105, Núm. 13, pp. 1853-1861

  2. Combining statistical techniques to predict postsurgical risk of 1-year mortality for patients with colon cancer

    Clinical Epidemiology, Vol. 10, pp. 235-251

  3. Predictors of one and two years’ mortality in patients with colon cancer: A prospective cohort study

    PLoS ONE, Vol. 13, Núm. 6

  4. Validación externa de la escala EAHFE-3D para la evaluación del pronóstico en insuficiencia cardiaca aguda

    Emergencias, Vol. 30, Núm. 2, pp. 84-90

  5. Validity of the CR-POSSUM model in surgery for colorectal cancer in Spain (CCR-CARESS study) and comparison with other models to predict operative mortality

    BMC Health Services Research, Vol. 18, Núm. 1

2016

  1. Colorectal cancer health services research study protocol: The CCR-CARESS observational prospective cohort project

    BMC Cancer, Vol. 16, Núm. 1

2008

  1. Tumor necrosis factor alpha drugs in rheumatoid arthritis: Systematic review and metaanalysis of efficacy and safety

    BMC Musculoskeletal Disorders, Vol. 9